Literature DB >> 15677897

Cancer in the Sami population of North Norway, 1970-1997.

T Haldorsen1, T Tynes.   

Abstract

The Sami population in North Norway constitutes an ethnic minority with a lifestyle that diverges from that of the rest of the population. A cohort of 19 801 people of Sami origin was followed for cancer incidence over the period 1970-1997 by the Norwegian Cancer Registry. Among the Sami 1340 cases of cancer were observed versus 1658.2 expected, based on a regional reference population. For both sexes a significantly decreased incidence of colon cancer was observed. The standardized incidence ratio (SIR) for men was 0.50 (95% confidence interval (CI) 0.34-0.71) and for women 0.62 (95% CI 0.43-0.85). Low SIRs were observed for lung cancer: 0.63 (95% CI 0.51-0.77) and 0.60 (95% CI 0.37-0.91), for men and women, respectively. Men of Sami ancestry had a decreased risk of prostate cancer: SIR 0.57 (95% CI 0.45-0.71). Among women 127 cases of breast cancer were observed versus 149.6 expected. A relatively high physical activity and a diet rich in fish may in part explain the low cancer incidence. Some Sami were exposed to radioactivity as a result of their diet based on reindeer products. Adverse effects on their cancer incidence were not observed.

Entities:  

Mesh:

Year:  2005        PMID: 15677897     DOI: 10.1097/00008469-200502000-00009

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  12 in total

1.  Circadian disruption induced by light-at-night accelerates aging and promotes tumorigenesis in rats.

Authors:  Irina A Vinogradova; Vladimir N Anisimov; Andrey V Bukalev; Anna V Semenchenko; Mark A Zabezhinski
Journal:  Aging (Albany NY)       Date:  2009-10-02       Impact factor: 5.682

2.  Light-at-night, circadian disruption and breast cancer: assessment of existing evidence.

Authors:  Richard G Stevens
Journal:  Int J Epidemiol       Date:  2009-04-20       Impact factor: 7.196

3.  Cancer in the Sami population of Sweden in relation to lifestyle and genetic factors.

Authors:  Sven Hassler; Per Sjölander; Henrik Grönberg; Robert Johansson; Lena Damber
Journal:  Eur J Epidemiol       Date:  2008-03-06       Impact factor: 8.082

4.  Sami-speaking municipalities and a control group's access to somatic specialist health care (SHC): a retrospective study on general practitioners' referrals.

Authors:  Jan Norum; Carsten Nieder
Journal:  Int J Circumpolar Health       Date:  2012-03-19       Impact factor: 1.228

5.  Occurrence of pancreatic, biliary tract, and gallbladder cancers in Alaska Native people, 1973-2007.

Authors:  Steven R Alberts; Janet J Kelly; Ramkumar Ashokkumar; Anne P Lanier
Journal:  Int J Circumpolar Health       Date:  2012-03-20       Impact factor: 1.228

6.  Survival of Sami cancer patients.

Authors:  Leena Soininen; Arun Pokhrel; Tadek Dyba; Eero Pukkala; Timo Hakulinen
Journal:  Int J Circumpolar Health       Date:  2012-07-02       Impact factor: 1.228

7.  Health consumption in Sami speaking municipalities and a control group with regard to medical imaging.

Authors:  Jan Størmer; Jan Norum; Lena Ringstad Olsen; Petter Eldevik; Ann Ragnhild Broderstad
Journal:  Int J Circumpolar Health       Date:  2012-03-23       Impact factor: 1.228

8.  Mammographic screening in Sami speaking municipalities and a control group. Are early outcome measures influenced by ethnicity?

Authors:  Jan Norum; Solveig Hofvind; Carsten Nieder; Edrun Andrea Schnell; Ann Ragnhild Broderstad
Journal:  Int J Circumpolar Health       Date:  2012-04-16       Impact factor: 1.228

9.  Socioeconomic characteristics and health outcomes in Sami speaking municipalities and a control group in northern Norway.

Authors:  Jan Norum; Carsten Nieder
Journal:  Int J Circumpolar Health       Date:  2012-08-20       Impact factor: 1.228

10.  Induced abortion on demand and birth rate in Sami-speaking municipalities and a control group in Finnmark, Norway.

Authors:  Jan Norum; Tove E Svee; Anca Heyd; Carsten Nieder
Journal:  Int J Circumpolar Health       Date:  2013-05-14       Impact factor: 1.228

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.